| (210) | Number of the EPO application | 16856278 |
| (220) | Filing date of the EPO application | 2016.10.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2021, 2021.10.06 |
| (110) | EPO patent number | 3362066 |
| (11) | Number of the document | MD 3362066 T2 |
| (21) | Number of the application | e 2018 0820 |
| (71) | Name(s) of applicant(s), code of the country | LES Laboratoires Servier SAS, FR;
Celgene Corporation, US; |
| (72) | Name(s) of inventor(s), code of the country | AGRESTA Samuel V., US;
VISWANADHAN Krishnan, US;
DIMARTINO Jorge, US;
CHOPRA Vivek Saroj Kumar, US;
MACBETH Kyle J., US;
KNIGHT Robert Douglas, US;
KENVIN Laurie, US;
XU Qiang, US; |
| (73) | Name(s) of owner(s), code of the country | LES LABORATOIRES SERVIER, FR;
Celgene Corporation, US; |
| (54) | Title of the invention | Combination therapy for treating malignancies |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/4439 (2006.01.01); C07H 19/12 (2006.01.01); A61P 35/00 (2006.01.01); A61K 45/06 (2006.01.01); A61K 31/444 (2006.01.01); A61K 31/706 (2006.01.01); A61P 35/02 (2006.01.01) |
| (19) | Country | FR |
| (41) | Date of publication of the application | 2018.10.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.08.31 |
| (30) | Priority | 201562242282 P, 2015.10.15, US |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| | Change of the owner | | erată titular | | | Nr. şi data deciziei: | 8253, 10.06.2022 | | Datele iniţiale: | Les Laboratoires Servier SAS, Republica Franţa;
Celgene Corporation, Statele Unite Ale Americii;
| | Datele finale: | Les Laboratoires Servier, Republica Franţa;
Celgene Corporation, Statele Unite Ale Americii; |
|
| (86) | International application | PCT/US2016/057042, 2016.10.14 |
| (87) | International publication | WO 2017/066571, 2017.04.20 |